VOV.VN - Vietnam Vaccine JSC (VNVC) began administering the pneumococcal 15-valent conjugate vaccine (PCV15 or Vaxneuvance) ...

Data cutoff date for Phase 2b NAVIGATE trial efficacy reached on April 30, 2025; top-line data readout expected in late June ...

Sutro Biopharma, Inc.’s STRO share price has dipped by 8.30%, which has investors questioning if this is right time to buy.

DB-1305/BNT325 was generally well tolerated and exhibited “very encouraging and durable antitumor activity in ovarian cancer patients,” said Maria Rubinstein, MD.

Regulatory Interactions and Commercial, Medical, and Corporate Preparations On-Track for Paltusotine New Drug Application ...

In April 2025, our partner Jazz announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of ...

AstraZeneca (AZN) and Daiichi Sankyo (DSNKY) announce that Enhertu hit the main goal in a Phase 3 trial for early-stage ...

Programmed cell death protein 1 (PD-1) and vascular endothelial growth factor (VEGF) are often co-expressed in the tumor microenvironment. The combination of anti-PD-1 and anti-VEGF agents has been ...

Corbus Pharmaceuticals Holdings, Inc.’s CRBP share price has surged by 5.55%, which has investors questioning if this is ...